Table 1.
Characteristics of patient tumors.
| Sample | Age of patient (years) | ER% | PR% | Her2 | Ki67% | Sample type | Histological tumor type |
|---|---|---|---|---|---|---|---|
| T84 | 57 | 80 | 80 | Negative | 10 | Primary, untreated | Mixed lobular/NST |
| T99 | 57 | 100 | 70 | Negative | 20 | Primary, untreated | NST |
| T105 | 59 | 80 | 100 | Negative | 20 | Primary, untreated | Lobular |
| T109 | 44 | 100 | 100 | 10 | Primary, untreated | NST | |
| T110 | 51 | 80 | 10 | Negative | 25 | Primary, untreated | NST |
| T111 | 44 | 100 | 100 | 10 | Primary, untreated | Mixed NST/lobular | |
| T113 | 70 | NA | NA | NA | NA | Primary, untreated | NA |
| T11 | 50 | NA | NA | NA | NA | Primary, untreated | NST |
| PL-015 | 59 | 90 | 100 | Negative | NA | Ascites, treated: chemo, aromatase inhibitors, fulvestrant | NST |
The table displays characteristics of patient tumors used in this study; the last column shows the response to P4 as MIND PDX.